Market control on analysis devices of the total, free and complexed PSA forms in serum

被引:1
|
作者
Le Brun, Gaelle [1 ]
Fulla, Yvonne [2 ]
Assicot, Marcel [3 ]
Conquy, Sophie [2 ]
Ramirez, Jose
Riedinger, Jean-Marc [4 ]
Morin, Jean-Francois [5 ]
机构
[1] Afssaps, F-93285 St Denis, France
[2] CHU Cochin, Paris, France
[3] IGR, Villejuif, France
[4] Ctr Reg Lutte Contre Canc, Dijon, France
[5] CHU Morvan, Brest, France
来源
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2007年 / 22卷 / 04期
关键词
D O I
10.1016/j.immbio.2007.02.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:247 / 259
页数:13
相关论文
共 50 条
  • [31] Extent of prostatic atrophy in needle biopsies and serum PSA levels (total, free or free/total ratio): Is there correlation?
    Ferreira, U
    Billis, A
    Meirelles, LR
    Magna, LA
    Baracat, J
    Prando, A
    Pedro, RN
    Matheus, WE
    Netto, NR
    JOURNAL OF UROLOGY, 2006, 175 (04): : 439 - 439
  • [32] A comparison of serum levels of total prostate specific antigen (PSA) and the free to total PSA ratio in detecting prostatic adenocarcinoma.
    Henricks, WH
    England, BG
    Giacherio, DA
    Oesterling, JE
    Wojno, KJ
    CLINICAL CHEMISTRY, 1996, 42 (06) : 699 - 699
  • [33] Significance of free to total PSA ratio in men with slightly elevated serum PSA levels: A cooperative study
    Kuriyama, M
    Kawada, Y
    Arai, K
    Maeda, H
    Egawa, S
    Koshiba, K
    Imai, K
    Yamanaka, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (11) : 661 - 665
  • [34] Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)
    Diamandis, Eleftherios P.
    Stanczyk, Frank Z.
    Wheeler, Sarah
    Mathew, Anu
    Stengelin, Martin
    Nikolenko, Galina
    Glezer, Eli N.
    Brown, Marshall D.
    Zheng, Yingye
    Chen, Yen-Hao
    Wu, Hsiao-Li
    Azziz, Ricardo
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (11) : 1789 - 1797
  • [35] Diagnostic utility of total PSA, free PSA and PSA density at total serum PSA levels below 4 ng/ml compared to total serum PSA levels between 4.1 and 10.0 ng/ml in an early prostate cancer detection programme
    Berger, A
    Pelzer, A
    Niescher, M
    Rogatsch, H
    Klocker, H
    Bartsch, G
    Horninger, W
    JOURNAL OF UROLOGY, 2003, 169 (04): : 277 - 277
  • [36] Two-year stability of free and total PSA in frozen serum samples
    Woodrum, D
    York, L
    UROLOGY, 1998, 52 (02) : 247 - 251
  • [37] Clinical utility of total, free and complexed-PSA in the diagnosis of prostate carcinoma and benign prostate hyperplasia.
    Gaspar, MI
    Angulo, J
    Arribas, I
    Coca, MC
    CLINICAL CHEMISTRY, 1999, 45 (06) : A106 - A106
  • [38] Alpha-1 antichymotrypsin complexed PSA in men under-going prostate biopsy offers significant advantage for the detection of carcinoma over total PSA and free-to-total PSA.
    Meyer, GE
    Brawer, MK
    Letran, JL
    Ransom, SD
    JOURNAL OF UROLOGY, 1998, 159 (05): : 72 - 72
  • [39] SENSITIVITY AND SPECIFICITY OF SERUM PSA, FREE TO TOTAL PSA RATIO AND TRANSRECTAL ULTRASONOGRAPHY FINDINGS IN PROSTATE CANCER DETECTION
    Ghorbani, Hamid Reza
    Zawarei, Mansour Jamali
    Ayati, Mohsen
    Nowroozi, Mohammad Reza
    Jamshidian, Hassan
    Ghasemi, Faezeh
    Nazari, Hamid
    Rajai, Bentelhoda
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A202 - A202
  • [40] Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests
    Liu, Tao
    Hossain, Mahmud
    Schepmoes, Athena A.
    Fillmore, Thomas L.
    Sokoll, Lori J.
    Kronewitter, Scott R.
    Izmirlian, Grant
    Shi, Tujin
    Qian, Wei-Jun
    Leach, Robin J.
    Thompson, Ian M.
    Chan, Daniel W.
    Smith, Richard D.
    Kagan, Jacob
    Srivastava, Sudhir
    Rodland, Karin D.
    Camp, David G., II
    JOURNAL OF PROTEOMICS, 2012, 75 (15) : 4747 - 4757